trans-Pralsetinib (Synonyms: trans-BLU-667) |
| Catalog No.GC61346 |
Le trans-pralsetinib (trans-BLU-667) est un inhibiteur réarrangé pendant la transfection (RET) extrait du brevet US20170121312A1, exemple de composé 129.
Products are for research use only. Not for human use. We do not sell to patients.
Cas No.: 2097132-93-7
Sample solution is provided at 25 µL, 10mM.
;)
,-1-7$$$37316672.jpg');)
;)
;)
$$$36806353.jpg');)
;33(7)%EF%BC%9A546-561$$$37156877.jpg');)
;)
;)
;)
%201124-1138.$$$35908550.jpg');)
%20766-780.$$$37100057.jpg');)
%20418-432.$$$36893736.jpg');)
%EF%BC%9A-240-255.$$$35108512.jpg');)
533-545$$$36543525.jpg');)
%201-13.$$$36600053.jpg');)
;)
trans-Pralsetinib (trans-BLU-667) is a rearranged during transfection (RET) inhibitor extracted from patent US20170121312A1, Compound Example 129[1].
[1]. Jason D. Brubaker, et al. Inhibitors of ret. US20170121312A1.
Review for trans-Pralsetinib
Average Rating: 5 (Based on Reviews and 27 reference(s) in Google Scholar.)
Review for trans-Pralsetinib
GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.
Required fields are marked with *